Nils Koch‐Henriksen

6.9k total citations · 1 hit paper
93 papers, 4.8k citations indexed

About

Nils Koch‐Henriksen is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Nils Koch‐Henriksen has authored 93 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Pathology and Forensic Medicine, 25 papers in Rheumatology and 21 papers in Neurology. Recurrent topics in Nils Koch‐Henriksen's work include Multiple Sclerosis Research Studies (83 papers), Systemic Lupus Erythematosus Research (23 papers) and Peripheral Neuropathies and Disorders (19 papers). Nils Koch‐Henriksen is often cited by papers focused on Multiple Sclerosis Research Studies (83 papers), Systemic Lupus Erythematosus Research (23 papers) and Peripheral Neuropathies and Disorders (19 papers). Nils Koch‐Henriksen collaborates with scholars based in Denmark, United States and United Kingdom. Nils Koch‐Henriksen's co-authors include Per Soelberg Sørensen, Melinda Magyari, Egon Stenager, Bjarne Laursen, Klaus Bendtzen, Esben Meulengracht Flachs, Finn Sellebjerg, Annette Oturai, Claudia Pfleger and Lau Caspar Thygesen and has published in prestigious journals such as The Lancet, Brain and Neurology.

In The Last Decade

Nils Koch‐Henriksen

91 papers receiving 4.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The changing demographic pattern of multiple sclerosis epidemiology

2010 877 citations Nils Koch‐Henriksen, Per Soelberg Sørensen The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nils Koch‐Henriksen Denmark	37	3.7k	1.0k	973	959	909	93	4.8k
Óscar Fernández Spain	35	3.1k 0.8×	960 1.0×	1.1k 1.2×	1.2k 1.2×	956 1.1×	199	4.9k
Aaron Miller United States	31	2.9k 0.8×	952 0.9×	604 0.6×	1.2k 1.2×	676 0.7×	119	4.0k
Daniel Wynn United States	26	2.7k 0.7×	653 0.7×	792 0.8×	1.1k 1.2×	1.0k 1.1×	50	3.6k
John Rose United States	35	3.7k 1.0×	1.2k 1.2×	1.6k 1.6×	1.8k 1.9×	986 1.1×	144	5.9k
Jeremy Chataway United Kingdom	39	2.6k 0.7×	762 0.8×	767 0.8×	1.1k 1.1×	524 0.6×	171	5.1k
Jelena Drulović Serbia	37	3.2k 0.9×	929 0.9×	752 0.8×	1.2k 1.3×	432 0.5×	174	4.7k
Giulio Disanto United Kingdom	35	3.4k 0.9×	556 0.6×	808 0.8×	1.3k 1.3×	767 0.8×	93	5.4k
Anders Svenningsson Sweden	38	3.4k 0.9×	620 0.6×	1.2k 1.2×	1.7k 1.7×	1.1k 1.2×	110	5.4k
S. Fredrikson Sweden	45	4.2k 1.1×	1.0k 1.0×	1.9k 2.0×	1.8k 1.8×	903 1.0×	198	7.5k
Neil P. Robertson United Kingdom	38	2.9k 0.8×	822 0.8×	1.2k 1.2×	1.6k 1.6×	537 0.6×	151	4.9k

Countries citing papers authored by Nils Koch‐Henriksen

Since Specialization

Citations

This map shows the geographic impact of Nils Koch‐Henriksen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Koch‐Henriksen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Koch‐Henriksen more than expected).

Fields of papers citing papers by Nils Koch‐Henriksen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nils Koch‐Henriksen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Koch‐Henriksen. The network helps show where Nils Koch‐Henriksen may publish in the future.

Co-authorship network of co-authors of Nils Koch‐Henriksen

This figure shows the co-authorship network connecting the top 25 collaborators of Nils Koch‐Henriksen. A scholar is included among the top collaborators of Nils Koch‐Henriksen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nils Koch‐Henriksen. Nils Koch‐Henriksen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Magyari, Melinda & Nils Koch‐Henriksen. (2022). Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 93(7). 716–722. 38 indexed citations

Iaffaldano, Pietro, Giuseppe Lucisano, Helmut Butzkueven, et al.. (2021). Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network. Multiple Sclerosis Journal. 27(10). 1543–1555. 36 indexed citations

Papp, Viktoria, Melinda Magyari, Nils Koch‐Henriksen, et al.. (2021). Population-based head-to-head comparison of the clinical characteristics and epidemiology of AQP4 antibody-positive NMOSD between two European countries. Multiple Sclerosis and Related Disorders. 51. 102879–102879. 3 indexed citations

Koch‐Henriksen, Nils, Per Soelberg Sørensen, & Melinda Magyari. (2021). Relapses add to permanent disability in relapsing multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 53. 103029–103029. 6 indexed citations

Koch‐Henriksen, Nils, Lau Caspar Thygesen, Egon Stenager, Bjarne Laursen, & Melinda Magyari. (2018). Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women. Neurology. 90(22). e1954–e1963. 130 indexed citations

Magyari, Melinda, Nils Koch‐Henriksen, Lau Caspar Thygesen, et al.. (2017). Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977–2015: A nationwide population-based incidence study. Multiple Sclerosis Journal. 24(8). 1077–1086. 39 indexed citations

Magyari, Melinda, et al.. (2016). Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark. Journal of Neurology. 263(12). 2484–2493. 43 indexed citations

Koch‐Henriksen, Nils, Melinda Magyari, & Bjarne Laursen. (2015). Registers of multiple sclerosis in Denmark. Acta Neurologica Scandinavica. 132(199). 4–10. 51 indexed citations

Sellebjerg, Finn, Helle Bach Søndergaard, Nils Koch‐Henriksen, Per Soelberg Sørensen, & Annette Oturai. (2014). Prediction of response to interferon therapy in multiple sclerosis. Acta Neurologica Scandinavica. 130(4). 268–275. 19 indexed citations

10.

Sørensen, Per Soelberg, Nils Koch‐Henriksen, Thor Petersen, et al.. (2014). Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients. Journal of Neurology. 261(6). 1170–1177. 111 indexed citations

11.

Galea, Ian, Christian Lederer, Ain Neuhaus, et al.. (2012). A Web‐based tool for personalized prediction of long‐term disease course in patients with multiple sclerosis. European Journal of Neurology. 20(7). 1107–1109. 18 indexed citations

12.

Bentzen, Joan, Lau Caspar Thygesen, Esben Meulengracht Flachs, et al.. (2010). Diagnostic delay in multiple sclerosis. Multiple Sclerosis Journal. 16. 1 indexed citations

13.

Bramow, Stephan, Josa M. Frischer, Hans Lassmann, et al.. (2010). Demyelination versus remyelination in progressive multiple sclerosis. Brain. 133(10). 2983–2998. 230 indexed citations

14.

Koch‐Henriksen, Nils & Per Soelberg Sørensen. (2010). The changing demographic pattern of multiple sclerosis epidemiology. The Lancet Neurology. 9(5). 520–532. 877 indexed citations breakdown →

15.

Rostgaard, Klaus, Johan Askling, Rudi Steffensen, et al.. (2009). Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Multiple Sclerosis Journal. 15(4). 431–436. 73 indexed citations

16.

Rostgaard, Klaus, Nete Munk Nielsen, Nils Koch‐Henriksen, et al.. (2007). Multiple Sclerosis After Infectious Mononucleosis. Archives of Neurology. 64(1). 72–72. 150 indexed citations

17.

Nielsen, Nete Munk, Tine Westergaard, Morten Frisch, et al.. (2006). Type 1 Diabetes and Multiple Sclerosis. Archives of Neurology. 63(7). 1001–1001. 92 indexed citations

18.

Sørensen, Per Soelberg, Christian Roß, Katja Maria Clemmesen, et al.. (2003). Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis. The Lancet. 362(9391). 1184–1191. 276 indexed citations

19.

Schreiber, Karen, Per Soelberg Sørensen, Nils Koch‐Henriksen, et al.. (2001). Correlations of brain MRI parameters to disability in multiple sclerosis. Acta Neurologica Scandinavica. 104(1). 24–30. 31 indexed citations

20.

Oturai, Annette, Lars P. Ryder, Hans O. Madsen, et al.. (1999). Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis. Annals of Neurology. 46(4). 612–616. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact